Literature DB >> 19468217

Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study.

Fred Rincon1, Ralph L Sacco, Grace Kranwinkel, Qiu Xu, Myungee C Paik, Bernadette Boden-Albala, Mitchell S V Elkind.   

Abstract

BACKGROUND: To assess the prevalence of risk factors as determinants of intracranial atherosclerosis (IATH)-related stroke in a multi-ethnic community-based cohort.
METHODS: The Northern Manhattan Stroke Study included a population-based incidence study and a nested case-control study. Incident cases of first ischemic stroke were 1:2 when matched to community controls by age, sex, and race/ethnicity. Vascular risk factors were assessed among controls and compared against the following stroke subtypes: IATH, extracranial atherosclerosis (EATH), and non-atherosclerotic (NATH: cardioembolic, lacunar, and cryptogenic). Conditional logistic-regression was used to determine the association between risk factors and stroke subtypes.
RESULTS: The crude incidence of IATH was 8/100,000 per year and the relative incidence of IATH was higher than that of EATH in blacks (5.9 vs. 3.2/100,000 per year) and in Hispanics (5.0 vs. 1.7/100,000 per year). The IATH group had a higher prevalence of diabetes mellitus (DM; 67% IATH, 60% EATH, 48% NATH, and 23% controls; p < 0.05 IATH vs. control) and of metabolic syndrome (62% IATH, 40% EATH, 40% NATH, and 35% controls; p < 0.05 IATH vs. control). In multivariate analysis, DM conferred a higher risk for IATH versus NATH stroke (OR, 10.8; 95% CI, 2.0-57 vs. OR, 2.7; 95% CI, 1.9-3.9; p < 0.05) and much lower for EATH (OR, 6.2; 95% CI, 1.2-32). The metabolic syndrome conferred a higher risk for IATH stroke subtype (OR, 4.6; 95% CI, 1.1-18.7) when compared to EATH (OR, 2.3; CI, 0.6-9.1) and NATH (OR, 2.4; CI, 1.7-3.3).
CONCLUSIONS: DM is a more important determinant for IATH-related stroke than EATH or NATH. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19468217      PMCID: PMC2914420          DOI: 10.1159/000219299

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  26 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Chinese-white differences in the distribution of occlusive cerebrovascular disease.

Authors:  E Feldmann; N Daneault; E Kwan; K J Ho; M S Pessin; P Langenberg; L R Caplan
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

3.  Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study.

Authors:  R L Sacco; B Boden-Albala; G Abel; I F Lin; M Elkind; W A Hauser; M C Paik; S Shea
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

4.  Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial.

Authors: 
Journal:  N Engl J Med       Date:  1985-11-07       Impact factor: 91.245

5.  Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.

Authors:  John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

6.  Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study.

Authors:  Bernadette Boden-Albala; Ralph L Sacco; Hye-Sueng Lee; Cairistine Grahame-Clarke; Tanja Rundek; Mitchell V Elkind; Clinton Wright; Elsa-Grace V Giardina; Marco R DiTullio; Shunichi Homma; Myunghee C Paik
Journal:  Stroke       Date:  2007-12-06       Impact factor: 7.914

7.  Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness.

Authors:  Angelo Scuteri; Samer S Najjar; Denis C Muller; Reubin Andres; Hidetaka Hougaku; E Jeffrey Metter; Edward G Lakatta
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

8.  The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

Authors:  Cynthia J Girman; Thomas Rhodes; Michele Mercuri; Kalevi Pyörälä; John Kjekshus; Terje R Pedersen; Polly A Beere; Antonio M Gotto; Michael Clearfield
Journal:  Am J Cardiol       Date:  2004-01-15       Impact factor: 2.778

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm.

Authors:  Jobien K Olijhoek; Yolanda van der Graaf; Jan-Dirk Banga; Ale Algra; Ton J Rabelink; Frank L J Visseren
Journal:  Eur Heart J       Date:  2004-02       Impact factor: 29.983

View more
  35 in total

1.  Decrease in circulating myeloid dendritic cell precursors in patients with intracranial large artery atherosclerosis.

Authors:  Jin-Xia Zhang; Bing-Ling Li; Zhong-Qiu Lin; Ni Zhang; Xiong Peng; Zhi-Hua Gong; Liu-Cheng Long; Xuan Zhou; Ding-Cheng Xiang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Middle cerebral artery stenosis in patients with acute ischemic stroke and TIA in Israel.

Authors:  G Telman; H Hurani; E Sprecher; E Kouperberg
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-14       Impact factor: 3.825

Review 3.  Genetic Risk Factors of Intracranial Atherosclerosis.

Authors:  Minghua Liu; Jose Gutierrez
Journal:  Curr Atheroscler Rep       Date:  2020-05-21       Impact factor: 5.113

4.  Risk factors associated with severity and location of intracranial arterial stenosis.

Authors:  Tanya N Turan; Achraf A Makki; Samuel Tsappidi; George Cotsonis; Michael J Lynn; Harry J Cloft; Marc I Chimowitz
Journal:  Stroke       Date:  2010-07-08       Impact factor: 7.914

5.  Prevalence of intracranial large artery stenosis and occlusion in patients with acute ischaemic stroke or TIA.

Authors:  Alessia Mattioni; Silvia Cenciarelli; Geert Biessels; Tom van Seeters; Ale Algra; Stefano Ricci
Journal:  Neurol Sci       Date:  2014-03       Impact factor: 3.307

Review 6.  Management of extracranial carotid artery disease.

Authors:  Yinn Cher Ooi; Nestor R Gonzalez
Journal:  Cardiol Clin       Date:  2015-02       Impact factor: 2.213

7.  Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.

Authors:  Ashkan Shoamanesh; Lesly A Pearce; Carlos Bazan; Luciana Catanese; Leslie A McClure; Mukul Sharma; Joan Marti-Fabregas; David C Anderson; Carlos S Kase; Robert G Hart; Oscar R Benavente
Journal:  Ann Neurol       Date:  2017-07-19       Impact factor: 10.422

8.  Advances in imaging of intracranial atherosclerotic disease and implications for treatment.

Authors:  Fan Z Caprio; Shyam Prabhakaran
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-06

9.  Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV.

Authors:  Jose Gutierrez; James Goldman; Andrew J Dwork; Mitchell S V Elkind; Randolph S Marshall; Susan Morgello
Journal:  Neurology       Date:  2015-08-28       Impact factor: 9.910

Review 10.  Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment.

Authors:  Christine A Holmstedt; Tanya N Turan; Marc I Chimowitz
Journal:  Lancet Neurol       Date:  2013-11       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.